Mode
Text Size
Log in / Sign up
N/A Completed N=231 Randomized Double-blind Treatment

Clinical Outcomes Following Treatment With SYSTANE® BALANCE

Source: ClinicalTrials.gov NCT02776670 ↗
Enrolled (actual)
231
Serious AEs
0.4%
Results posted
Jun 2019
Primary outcomePrimary: Mean Change From Baseline in Tear Film Break-Up Time (TFBUT) at Day 35 — 0.999; 0.864 seconds — p=<0.0001

Summary

The purpose of this study is to evaluate the clinical effectiveness of SYSTANE® BALANCE compared to REFRESH OPTIVE® Advanced in subjects with lipid-deficient dry eye.

Outcome Measures

OutcomeResultp-value
PRIMARY
Mean Change From Baseline in Tear Film Break-Up Time (TFBUT) at Day 35
0.999; 0.864 <0.0001 sig
SECONDARY
Change From Baseline in TFBUT at Day 35
0.985; 0.867 0.310
SECONDARY
Lipid Layer Thickness (LLT) Area Under the Curve (AUC120) at Day 35
— —
SECONDARY
Mean Change From Baseline in Global Ocular Discomfort Visual Analog Scale (VAS) Score at Day 35
-9.9; -8.8 0.618

Eligibility Criteria

Inclusion Criteria

  • Willing and able to attend all study visits;
  • Must sign an informed consent form;
  • Best-corrected visual acuity (BCVA) of 55 letters or better in each eye as assessed using an early treatment diabetic retinopathy study (ETDRS) chart;
  • Willing to take study products as directed for entire study;
  • Other protocol-specified inclusion criteria may apply.

Exclusion Criteria

  • Women of childbearing potential who are pregnant, plan to become pregnant during the study, breast feeding, or not using adequate birth control methods;
  • Contact lens use within 30 days prior to Screening Visit, or unwilling to avoid contact lens use during the course of the study;
  • Use of medication excluded by the protocol;
  • Diseases, illnesses, infections, or ocular abnormalities excluded by the protocol;
  • Ocular surgeries or procedures excluded by the protocol;
  • Other protocol-specified exclusion criteria may apply.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02776670). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search